Iridex Stock Today

IRIX Stock  USD 1.56  0.04  2.63%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Average

 
High
 
Low
IRIDEX is trading at 1.56 as of the 27th of January 2026; that is 2.63% increase since the beginning of the trading day. The stock's open price was 1.52. IRIDEX has 54 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. The performance scores are derived for the period starting the 29th of October 2025 and ending today, the 27th of January 2026. Click here to learn more.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. The company has 16.99 M outstanding shares of which 280.09 K shares are currently shorted by private and institutional investors with about 4.99 trading days to cover. More on IRIDEX

Moving against IRIDEX Stock

  0.52VZ Verizon Communications Earnings Call This WeekPairCorr
  0.5CSCO Cisco Systems Aggressive PushPairCorr
  0.41T ATT Inc Earnings Call TomorrowPairCorr
  0.38IBM International Business Earnings Call TomorrowPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

IRIDEX Stock Highlights

CEO PresidentDavid Bruce
Business ConcentrationHealth Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
IRIDEX (IRIX) is traded on NASDAQ Exchange in USA and employs 93 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.08 M. IRIDEX conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.99 M outstanding shares of which 280.09 K shares are currently shorted by private and institutional investors with about 4.99 trading days to cover. IRIDEX currently holds about 17.97 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12.
Check IRIDEX Probability Of Bankruptcy
Ownership Allocation
IRIDEX has a total of 16.99 Million outstanding shares. IRIDEX secures noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check IRIDEX Ownership Details

IRIDEX Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. IRIDEX market risk premium is the additional return an investor will receive from holding IRIDEX long position in a well-diversified portfolio.

IRIDEX Stock Against Markets

IRIDEX Corporate Management

Leigh SalvoHead RelationsProfile
Patrick MercerChief OfficerProfile
Fuad AhmadInterim OfficerProfile
Bassem BouHabibVice SalesProfile
Romeo DizonChief OfficerProfile

Additional Tools for IRIDEX Stock Analysis

When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.